00668pab a2200157 454500 180718b1999 xxu||||| |||| 00| 0 eng d Mirza, Zafar WTO/TRIPs, pharmaceuticals and health: impacts and strategies 1999 p.92-97 Dec Zafar Mirza looks at the problems of high drug prices, low access to medicines and the weakening of the national pharmaceutical industry for the majority of the world's population when the `Agreement on Trade-Related Aspects of Intellectual Property Rights' (TRIPs) is to be implemented. - Reproduced Drugs Development 43790 43790 43790 0 0 0 0 IIPA IIPA 2018-07-19 Volume no: 42, Issue no: 4 AR44192 2018-07-19 2018-07-19 AR